Vedolizumab for Immune Mediated Colitis

NCT04797325 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Immune-Mediated Colitis

Interventions

DRUG: Vedolizumab
DRUG: Prednisolone

Sponsor

University of Copenhagen